Loading Events

« All Events

  • This event has passed.

Financing of the PORPHYRIA project by SATT Aquitaine

26 April 2023

SATT Aquitaine invests in the maturation of innovative projects from regional public research. SATT Aquitaine’s objective is to mature these inventions, from the stage of research results to pre-industrialization (proof of concept), and to support them until they are brought to market.

Head by Pr Emmanuel RICHARD, PU-PH, head of the biochemistry department at Bordeaux University Hospital and member of theteam 08 – Biotherapies Genetics and Oncology (BioGO)in collaboration with Dr Oscar MILLET of the CICBioGUNE , Bilbao, the project PORPHYRIA aims to develop a pharmacological therapeutic option for erythropoietic porphyrias, a group of rare diseases of heme metabolism. The objective of the €568,000 investment by SATT Aquitaine is to identify and validate in-vitro and in-vivo a pharmacological inhibitor of the ALAS2 enzyme, previously identified as a therapeutic target by the BioGO team.

More information at this link


26 April 2023
Event Category: